Term: Belrapzo

Pronunciation: (bel-RAP-zoh)

Description:

A drug used to treat chronic lymphocytic leukemia and certain types of non-Hodgkin lymphoma. It is also being studied in the treatment of other types of cancer. Belrapzo damages the cell’s DNA and may kill cancer cells. It is a type of alkylating agent. Also called bendamustine hydrochloride, Bendeka, and Treanda.